Patent · US Active

Antibodies that specifically bind PD-1 and methods of use

US10995149B2 · kind B2 · utility

1Cited by
10References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2018
Grant dateMay 4, 2021
Priority date
Expiry dateJun 4, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.